U.K. Pulls Plug On Some Cough/Cold Products For Children Under 2
This article was originally published in The Tan Sheet
Executive Summary
The U.K. health authority has withdrawn its authorization for some nonprescription cough and cold products to be used with children under 2 years old, with the products restricted from over-the-counter sales until additional instructions for use with 2- to 6-year-old children are added to their labels
You may also be interested in...
U.K. To Move Kids’ Cough/Cold Drugs BTC, Redraws Age Recommendation
Manufacturers of pediatric cough/cold medicines sold in the U.K. have until March 2010 before the products must be sold behind the pharmacy counter, one of several measures to improve safe use
Australia pulls cough/cold products for under 2
The Australian Therapeutic Goods Administration follows in the footsteps of FDA and the U.K.'s Medicines and Healthcare products Regulatory Agency by restricting the use of certain OTC cough and cold medicines in children under 2 years of age, according to a memo TGA sent to pharmacists April 10. TGA also tells manufacturers to add labeling warning consumers not to use the products in children under 2. Additionally, TGA advises manufacturers to stop labeling previously approved products for children under 2 as safe, the memo says. The Australian regulatory agency came to its conclusion in part due to FDA's and MHRA's previous decisions to restrict the use of these products in children under 2 (1"The Tan Sheet" March 31, 2008, p. 9)...
Pediatric Cough/Cold OTC Safety Review Continues With Joint Panel Planned
FDA does not go far enough with its recent public health advisory on pediatric cough/cold OTCs to address the potential severe adverse events described in a citizen petition recommending labeling changes to the products, according to one of the petitioners